Compare SKYW & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SKYW | LIVN |
|---|---|---|
| Founded | 1972 | 1987 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Air Freight/Delivery Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.5B |
| IPO Year | 1994 | 2015 |
| Metric | SKYW | LIVN |
|---|---|---|
| Price | $99.05 | $80.27 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $123.67 | $72.43 |
| AVG Volume (30 Days) | 413.7K | ★ 698.1K |
| Earning Date | 04-23-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 33.20 | N/A |
| EPS | ★ 2.50 | 0.40 |
| Revenue | ★ $2,971,963,000.00 | N/A |
| Revenue This Year | $8.35 | $9.79 |
| Revenue Next Year | $3.55 | $6.63 |
| P/E Ratio | ★ $38.91 | $201.89 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $77.89 | $41.02 |
| 52 Week High | $123.94 | $85.27 |
| Indicator | SKYW | LIVN |
|---|---|---|
| Relative Strength Index (RSI) | 58.35 | 50.92 |
| Support Level | $95.25 | $61.63 |
| Resistance Level | $101.95 | $80.96 |
| Average True Range (ATR) | 2.77 | 2.17 |
| MACD | -0.35 | -0.65 |
| Stochastic Oscillator | 66.61 | 30.00 |
SkyWest Inc offers commercial air services in the United States, Canada, Mexico, and the Caribbean. Additionally, it leases aircraft to capable users to help generate revenue. SkyWest generally provides regional flights and utilizes smaller, lower-cost aircraft to carry passengers who book tickets through partner airlines. It partners with carriers to fly and operate aircraft for a fee and may use the carriers' brands and ground support to coordinate marketing and transport passengers. The company has two reportable segments: SkyWest Airlines and SWC, which generate maximum revenue, and SkyWest Leasing activities.
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.